Effects of ageing and Alzheimer disease on haemodynamic response function: A challenge for event-related fMRI

被引：9
作者：
Asemani D. [1 ,2 ]
Morsheddost H. [2 ]
Shalchy M.A. [2 ]
机构：
[1] Division of Radiology, Medical University of South Carolina, Charleston, 29407, SC
[2] Biomedical Engineering Department, K. N. Toosi University of Technology, Tehran
来源：
Asemani, Davud (asemani@musc.edu) | 2017年 / Institution of Engineering and Technology, United States卷 / 04期
关键词：
58;
D O I：
10.1049/htl.2017.0005
中图分类号：
学科分类号：
摘要：
Functional magnetic resonance imaging (fMRI) can generate brain images that show neuronal activity due to sensory, cognitive or motor tasks. Haemodynamic response function (HRF) may be considered as a biomarker to discriminate the Alzheimer disease (AD) from healthy ageing. As blood-oxygenation-level-dependent fMRI signal is much weak and noisy, particularly for the elderly subjects, a robust method is necessary for HRF estimation to efficiently differentiate the AD. After applying minimum description length wavelet as an extra denoising step, deconvolution algorithm is here employed for HRF estimation, substituting the averaging method used in the previous works. The HRF amplitude peaks are compared for three groups HRF of young, non-demented and demented elderly groups for both vision and motor regions. Prior works often reported significant differences in the HRF peak amplitude between the young and the elderly. The authors' experimentations show that the HRF peaks are not significantly different comparing the young adults with the elderly (either demented or non-demented). It is here demonstrated that the contradictory findings of the previous studies on the HRF peaks for the elderly compared with the young are originated from the noise contribution in fMRI data.
引用
收藏
页码：109 / 114
页数：5
相关论文
共 58 条
  • [1] Hao J., Li K., Li K., Et al., Visual attention deficits in Alzheimer's disease: An fMRI study, Neurosci. Lett., 385, pp. 18-23, (2005)
  • [2] Carr D.B., Goate A., Phil D., Et al., Current concepts in the pathogenesis of Alzheimer's disease, Am. J. Med., 103, pp. 3S-10S, (1997)
  • [3] Petrella J.R., Coleman R.E., Doraiswamy P.M., Neuroimaging and early diagnosis of Alzheimer disease: A look to the future, Radiology, 226, pp. 315-336, (2003)
  • [4] Tripoliti E.E., Fotiadis D.I., Argyropoulou M., A supervised method to assist the diagnosis and monitor progression of Alzheimer's disease using data from an fMRI experiment, Artif. Intell. Med., 53, pp. 35-45, (2011)
  • [5] Tripoliti E.E., Fotiadis D.I., Argyropoulou M., A supervised method to assist the diagnosis of Alzheimer's disease based on functional magnetic resonance imaging, Engineering in Medicine and Biology Society (EMBS), 29th Annual Int. Conf. of the IEEE, pp. 3426-3429, (2007)
  • [6] Scheltens P., Early diagnosis of dementia: Neuroimaging, J. Neurol., 246, pp. 16-20, (1999)
  • [7] Burggren A.C., Bookheimer S.Y., Structural and functional neuroimaging in Alzheimer's disease: An update, Curr. Top. Med. Chem., 2, pp. 385-393, (2002)
  • [8] Lu H., Xu F., Rodrigue K.M., Et al., Alterations in cerebral metabolic rate and blood supply across the adult lifespan, Cereb. Cortex, 21, pp. 1426-1434, (2011)
  • [9] Brown W.R., Thore C.R., Review: Cerebral microvascular pathology in ageing and neurodegeneration, Neuropathol. Appl. Neurobiol., 37, pp. 56-74, (2011)
  • [10] Chen J.J., Rosas H.D., Salat D.H., Age-associate reductions in cerebral blood flow are independent from regional atrophy, Neuroimage, 55, pp. 468-478, (2011)
123456